BSE   23 May 13 | 12:00 AM 1425.15 -25.5 (-1.76%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 500488 Face Value: 10

NSE   23 May 13 | 12:00 AM 1425.50 -24.9 (-1.72%) Mkt Price (Rs)   Chg Rs (Chg %) Code: ABBOTINDIA

Performance 1 Week : Rs 1,450.65 (-1.76%) 1 Month : Rs 1,375.10 (3.64%) 1 Year : Rs 1,442.95 (-1.23%)

Smart Charts | Add to my portfolio | Derivative

News 08 May 13 18:27 ABB India Q1 net down 11% 06 May 13 12:08 Angel recommends 'buy'' on Abbott India; target Rs 1,659 20 Feb 13 17:15 Abbott India Q4 net up 35% at Rs 50 cr 16 Mar 12 01:01 Rehan Khan is Abbott India MD 28 Feb 12 19:55 Abbott Q4 net profit at Rs 37 cr 19 Oct 11 19:16 Abbott to split into two companies

Stock Summary

Shareholding Pattern Promoters 74.99 % Mutual Funds / UTI 5.79 % FI/Bank 0.03 % Insurance 0.82 % Others 0.00 % Govt 0.00 % FII 0.01 % Non-Institutions 18.37 % Depository Receipts 0.00 % Total 100.00 %

Key Financials (Rs cr) Mar 2013 Mar 2012 YOY Operating Income 419.68 375.98 11.62 Total Expenses 373.77 336.23 11.17 Operating Profit 45.91 39.75 15.50 Other Income 6.37 5.30 20.19 PBDIT 52.28 45.05 16.05 PBT 47.04 39.12 20.25 Adjusted Net Profit 31.70 16.69 89.93

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Aurobindo Pharma 174.50 -4.25 5,082 Pfizer 1,047.30 -0.96 3,125 Jubilant Life 143.10 -5.20 2,279 Alembic Pharma 119.90 -3.54 2,260 Ajanta Pharma 960.65 -2.05 2,250

Funds Owning this Stock Scheme Name Value (Rs cr) Reliance Equity Opportunities Fund - Direct (G) 98.87 Reliance Equity Opportunities Fund - Inst (G) 72.66 Reliance Equity Opportunities Fund (G) 72.66 Reliance Pharma Fund - Direct (G) 30.88 Reliance Long-Term Equity Fund (G) 31.73

Announcements

Research Reports Date Broker Action Price (Rs) Report 17/11 Angel Broking Accumulate 1460 17/08 Angel Broking Neutral 1536 16/01 Angel Broking Buy 1434 13/03 Macquarie Not Rated 366